| Mutations of the Same Conserved Glutamate Residue in NBD2 of the Sulfonylurea Receptor 1 Subunit of the KATP Channel Can Result in Either Hyperinsulinism or Neonatal Diabetes. | |
| | |
MedLine Citation:
|
PMID: 21617188 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
OBJECTIVE Two novel mutations (E1506D, E1506G) in the nucleotide-binding domain 2 (NBD2) of the ATP-sensitive K(+) channel (K(ATP) channel) sulfonylurea receptor 1 (SUR1) subunit were detected heterozygously in patients with neonatal diabetes. A mutation at the same residue (E1506K) was previously shown to cause congenital hyperinsulinemia. We sought to understand why mutations at the same residue can cause either neonatal diabetes or hyperinsulinemia. RESEARCH DESIGN AND METHODS Neonatal diabetic patients were sequenced for mutations in ABCC8 (SUR1) and KCNJ11 (Kir6.2). Wild-type and mutant K(ATP) channels were expressed in Xenopus laevis oocytes and studied with electrophysiological methods. RESULTS Oocytes expressing neonatal diabetes mutant channels had larger resting whole-cell K(ATP) currents than wild-type, consistent with the patients' diabetes. Conversely, no E1506K currents were recorded at rest or after metabolic inhibition, as expected for a mutation causing hyperinsulinemia. K(ATP) channels are activated by Mg-nucleotides (via SUR1) and blocked by ATP (via Kir6.2). All mutations decreased channel activation by MgADP but had little effect on MgATP activation, as assessed using an ATP-insensitive Kir6.2 subunit. Importantly, using wild-type Kir6.2, a 30-s preconditioning exposure to physiological MgATP concentrations (>300 µmol/L) caused a marked reduction in the ATP sensitivity of neonatal diabetic channels, a small decrease in that of wild-type channels, and no change for E1506K channels. This difference in MgATP inhibition may explain the difference in resting whole-cell currents found for the neonatal diabetes and hyperinsulinemia mutations. CONCLUSIONS Mutations in the same residue can cause either hyperinsulinemia or neonatal diabetes. Differentially altered nucleotide regulation by NBD2 of SUR1 can explain the respective clinical phenotypes. |
| | |
Authors:
|
Roope Männikkö; Sarah E Flanagan; Xiuli Sim; David Segal; Khalid Hussain; Sian Ellard; Andrew T Hattersley; Frances M Ashcroft |
Related Documents
:
|
11549908 - Serum levels of advanced glycosylation end products in diabetic nephropathy. 12937228 - Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic prot... 20658438 - Mechanisms of diabetic nephropathy--old buddies and newcomers part 1. 22260488 - Childhood onset diabetes posttransplant in a girl with tcf2 mutation. 15237068 - Glycemic patterns detected by continuous subcutaneous glucose sensing in children and a... 3408348 - Total serum cholesterol and plasma lipoprotein cholesterol concentrations in cord sera ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Diabetes Volume: 60 ISSN: 1939-327X ISO Abbreviation: Diabetes Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-05-27 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372763 Medline TA: Diabetes Country: United States |
Other Details:
|
Languages: eng Pagination: 1813-22 Citation Subset: AIM; IM |
Affiliation:
|
Corresponding author: Frances M. Ashcroft, frances.ashcroft@dpag.ox.ac.uk. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: IL-13R{alpha}1 Expression on {beta}-Cell-Specific T Cells in NOD Mice.
Next Document: Sirolimus-based regimen is associated with decreased expression of glomerular vascular endothelial g...